Recall of Mylanta and Alternagel Liquid Products

Silver Spring, Maryland–(ENEWSPF)–December 1, 2010.  In consultation with the U.S. Food and Drug Administration (FDA), Johnson & Johnson-Merck Consumer Pharmaceuticals, Co. (JJMCP) is recalling, from the wholesale and retail level, twelve MYLANTA^® liquid products and one AlternaGEL^® liquid product. JJMCP is conducting the recall in order to update the labeling for these products. The specific products involved, listed below, are being recalled in the United States and Puerto Rico.